Merrimack Pharmaceuticals, Inc. MACK
15.15 +15.15
Day range unavailable
52-week range unavailable
MACK revenue history
Revenue is income from the company’s ordinary business activities.
0 USD
FY 2023 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2023 | 2023-12-31 | 0 | 0 | Not meaningful |
| FY 2022 | 2022-12-31 | 0 | 0 | Not meaningful |
| FY 2021 | 2021-12-31 | 0 | 0 | Not meaningful |
| FY 2020 | 2020-12-31 | 0 | 0 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | 0 | Not meaningful |
| FY 2017 | 2017-12-31 | 0 | 0 | Not meaningful |
| FY 2016 | 2016-12-31 | 0 | 0 | Not meaningful |
| FY 2015 | 2015-12-31 | 0 | -102,756,000 | -100.00% |
| FY 2014 | 2014-12-31 | 102,756,000 | 54,970,000 | 115.03% |
| FY 2013 | 2013-12-31 | 47,786,000 | -1,135,000 | -2.32% |
| FY 2012 | 2012-12-31 | 48,921,000 | 14,706,000 | 42.98% |
| FY 2011 | 2011-12-31 | 34,215,000 | 13,910,000 | 68.51% |
| FY 2010 | 2010-12-31 | 20,305,000 | 18,157,000 | 845.30% |
| FY 2009 | 2009-12-31 | 2,148,000 | 1,783,000 | 488.49% |
| FY 2008 | 2008-12-31 | 365,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:02:55.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.